Vitamin D helps the body absorb and use calcium and phosphorus, supports the development and maintenance of bones and teeth, and contributes to normal immune function. Biogénique Vitamin D3 supplies 25 micrograms of cholecalciferol—equivalent to 1,000 IU—per capsule. That is a licensed adult dose, but it is not a universal prescription, a reason to ignore food and sunlight, or proof that more vitamin D prevents fractures, infections, cancer, cardiovascular disease or depression.

What is vitamin D3?

Vitamin D is a fat-soluble nutrient. The two main supplemental forms are vitamin D2, or ergocalciferol, and vitamin D3, or cholecalciferol. D3 is also produced in human skin after ultraviolet B exposure. Vitamin D from sunlight, food or supplements is not fully active when it enters the body: the liver converts it to 25-hydroxyvitamin D, and the kidney and other tissues convert it further to the active hormone calcitriol.

Calcitriol influences calcium and phosphate balance and binds the vitamin D receptor in many tissues. Those biological actions help explain why vitamin D is essential, but they do not establish that a high supplement dose improves every condition in which a vitamin D receptor is present. Nutrient function, observational association and treatment efficacy are different levels of evidence.

What does 25 mcg or 1,000 IU mean?

Vitamin D labels use both micrograms and International Units. The conversion is fixed: 1 microgram of vitamin D equals 40 IU. Therefore, 25 micrograms equals 1,000 IU. These two numbers describe the same amount; they are not separate ingredients or doses.

An RDA is a population reference designed to meet the needs of nearly all healthy people. It includes vitamin D from food, fortified products and supplements. The Tolerable Upper Intake Level, or UL, is a risk-management ceiling—not a recommended goal. A licensed 1,000 IU capsule can fit within those boundaries, but the appropriate total still depends on diet, age, sun exposure, health history, medicines and laboratory findings.

How much vitamin D do people in Canada need?

Health Canada's public guidance recommends vitamin D from food or a supplement every day. For people aged 2 to 50, it advises eating vitamin-D-containing foods daily or taking a 400 IU supplement. For adults 51 and older, it recommends a daily 400 IU supplement while continuing to eat vitamin-D-containing foods. This public-health advice is not a statement that 400 IU is the only acceptable product dose.

The Canadian Dietary Reference Intake table lists 600 IU per day for healthy people aged 9 through 70 and 800 IU per day after age 70, assuming minimal sun exposure. Those values and the 400 IU supplement advice answer different questions: the RDA describes total intake, while the food-guide advice identifies a practical supplement step for the population. Biogénique's 1,000 IU capsule is the licensed product amount, not a replacement for individualized assessment.

Which vitamin D3 benefits are licensed in Canada?

The product licence for NPN 80086934 authorizes three core purposes: helping maintain proper immune function; helping the absorption and use of calcium and phosphorus; and helping in the development and maintenance of bones and teeth. These are credible nutrient-function statements and form the safest foundation for consumer education.

The wording matters. Vitamin D can support a normal process without a 1,000 IU capsule preventing or treating every disease associated with that process. The licence does not authorize claims that this product prevents influenza, treats depression, prevents heart attacks, builds muscle, cures osteoporosis or guarantees fewer fractures. Those promises should not be inferred from the phrase 'supports immune function' or from observational links between low vitamin D status and disease.

Vitamin D3, calcium and bone health

Vitamin D promotes calcium absorption in the intestine and helps maintain calcium and phosphate concentrations that support normal bone mineralization. Severe deficiency can cause rickets in children and osteomalacia in adults. Correcting inadequate vitamin D is therefore important, particularly when calcium intake, age, limited sunlight or malabsorption also affect bone health.

That mechanism does not mean supplementation prevents fractures in every healthy adult. In the large VITAL ancillary fracture trial, 2,000 IU of vitamin D3 daily did not significantly reduce total, nonvertebral or hip fractures among generally healthy middle-aged and older adults who were not selected for vitamin D deficiency, low bone mass or osteoporosis. People at risk of osteoporosis still need an overall plan that can include calcium intake, resistance and weight-bearing activity, fall prevention, appropriate testing and prescribed treatment.

Vitamin D3 and immune function

Vitamin D receptors and vitamin-D-activating enzymes are present in immune cells, and adequate vitamin D supports normal immune function. That licensed nutrient role is not the same as an antiviral treatment. Studies of respiratory infections vary by baseline status, dose, schedule, population and outcome, and a single positive trial does not justify a broad claim that vitamin D prevents colds or influenza.

Use the product to support adequate intake under its label—not as a substitute for vaccination, testing, antiviral treatment or medical care. Fever, breathing difficulty, dehydration, confusion or persistent symptoms require appropriate assessment regardless of supplement use.

Does vitamin D3 improve mood, heart health or cancer risk?

Low 25-hydroxyvitamin D concentrations can occur alongside chronic illness, lower outdoor activity, obesity, older age and other factors that also influence health outcomes. Observational associations therefore cannot prove that taking vitamin D will prevent a disease. NIH's evidence review reports that clinical trials have not shown vitamin D supplements to prevent or treat depressive symptoms in typical study populations, and trials have not confirmed cardiovascular protection.

Cancer evidence is also more nuanced than a headline. Trials have generally not shown a reduction in cancer incidence from vitamin D supplementation in the general population. A person with documented deficiency or a condition that alters vitamin D metabolism may still need treatment, but that clinical need should not be converted into a universal mood, heart or cancer claim for this 1,000 IU product.

Who is more likely to have low vitamin D status?

Vitamin D production from sunlight varies with season, latitude, cloud cover, smog, time of day, sunscreen use, time outdoors, amount of skin exposed, age and skin pigmentation. Health Canada notes that many of these factors apply to people living in Canada, which is why it recommends a daily food or supplement source rather than relying on sunlight alone.

Risk can also rise when the intestine does not absorb fat normally because vitamin D is fat-soluble. Celiac disease, Crohn's disease, ulcerative colitis, cystic fibrosis, some liver disorders and bariatric surgery can change absorption. People who are homebound, cover most of their skin, have little outdoor exposure, are older or have obesity may also need a more individualized assessment. Higher risk does not automatically determine the dose; it identifies who may benefit from clinical review.

Should vitamin D be tested?

The main blood marker is serum 25-hydroxyvitamin D, usually written 25(OH)D. It reflects vitamin D produced by the skin and obtained from food and supplements. The active hormone 1,25-dihydroxyvitamin D is generally not the routine status test because the body regulates it tightly and it can remain normal until deficiency is severe.

Routine screening of every healthy person is not universally recommended, and test interpretation varies by guideline and clinical context. Testing is more useful when symptoms, osteoporosis, repeated fractures, malabsorption, kidney or liver disease, bariatric surgery, medicines or a clinician-directed treatment plan make the result likely to change care. Do not chase a high blood level: excessive concentrations can be harmful.

What is the best time to take vitamin D3?

No strong evidence establishes morning or evening as universally superior. The best time is the one you can follow consistently. Because vitamin D is fat-soluble, taking the capsule with a meal or snack that contains some fat can improve absorption, although some vitamin D is absorbed even without dietary fat.

A practical routine is breakfast, lunch or dinner—whichever is easiest to remember and does not conflict with medicine instructions. If a clinician or pharmacist separates the supplement from another medicine, follow that advice. Do not double the next dose after forgetting one unless the current label or a health professional tells you to do so.

Is 1,000 IU of vitamin D3 safe every day?

For healthy adults, 1,000 IU per day is below the 4,000 IU adult UL and below Health Canada's 2,500 IU maximum non-prescription daily dose. Those ceilings are not personal guarantees. Total intake includes single-ingredient vitamin D, multivitamins, calcium-plus-D products, D3+K2 formulas, cod liver oil and fortified foods.

Vitamin D toxicity almost always results from excessive supplement use or dosing errors rather than sunlight. Too much vitamin D can raise blood calcium, causing nausea, vomiting, weakness, thirst, frequent urination, dehydration, confusion and kidney problems. Severe toxicity can cause kidney failure, abnormal heart rhythms and calcium deposits in soft tissues. More is not better, and the UL is not a target.

Medication and medical-condition cautions

The product licence specifically says to consult a healthcare practitioner before use if you are taking blood thinners. Keep that label warning even though other interaction resources focus more often on different drug classes. NIH also identifies potential issues with orlistat, statins, corticosteroids and thiazide diuretics. Thiazides reduce urinary calcium and can increase the risk of high blood calcium when combined with vitamin D, especially with kidney impairment or hyperparathyroidism.

People with kidney disease, kidney stones, high blood calcium, hyperparathyroidism or granulomatous conditions such as sarcoidosis can require individualized monitoring. Pregnancy, breastfeeding, childhood use and treatment of confirmed deficiency should follow the applicable current label or clinician plan rather than the general adult direction reviewed here.

• Ask a clinician before use if taking blood thinners, as required by the product licence.

• Ask a pharmacist about thiazide diuretics, steroids, orlistat, statins and other long-term medicines.

• Seek individualized advice with kidney disease, hypercalcemia, hyperparathyroidism, sarcoidosis, malabsorption or bariatric surgery.

• Do not use a retail supplement as unsupervised treatment for a documented severe deficiency.

Which foods provide vitamin D?

Vitamin D occurs naturally in relatively few foods. Health Canada highlights egg yolks and fatty fish such as salmon, Arctic char and rainbow trout. Fortified foods—including milk, fortified plant-based beverages and soft margarine—provide much of the dietary vitamin D in Canada. The Nutrition Facts table shows vitamin D when it has been added.

A supplement can provide a predictable amount when food intake is inconsistent, but it does not replace the protein, calcium, essential fats and other nutrients supplied by a balanced diet. The most useful plan combines a realistic food pattern, safe sun practices and supplementation when appropriate.

What is actually in Biogénique Vitamin D3?

Biogénique Vitamin D3 carries Natural Product Number 80086934. The product licence, approved front image and live product page support the core identity below. Packaging conflicts are shown explicitly instead of being blended into one assumed label.

One archived artwork/PDF file named 'Vitamin D3 1000 IU 80086934' prints NPN 80068127 inside the label, while the licence, approved front image and live page support 80086934. The artwork archive also shows lot 240539 with an April 2027 expiry, but that lot's certificate belongs to Hawthorn. These are publication-control problems, not reasons to alter the licensed formula in the article. The current bottle remains the final source for ingredients, lot and expiry until the archive is corrected.

What do the reviewed Certificates of Analysis show?

The closest product-specific capsule certificate is Biogénique Vitamin D3 lot 230919, manufactured in September 2023 with an August 2025 expiry. It lists 25 mcg/1,000 IU of cholecalciferol as the formula, a 446.50 mg average capsule weight and a seven-minute disintegration result against a not-more-than-30-minute specification. As of 20 August 2026, the certificate is expired.

That certificate reports total plate count of 510 CFU/g, yeast and mould of 40 CFU/g, and negative results for E. coli, Salmonella, Staphylococcus aureus and Pseudomonas aeruginosa. It also reports arsenic, cadmium, lead and mercury values below its stated limits. It does not contain a finished-product vitamin D3 assay or potency result, and its non-medicinal ingredients include silicon dioxide and magnesium stearate in addition to microcrystalline cellulose and hypromellose—another reason not to treat it as the current label record.

A second file titled Vitamin D3 lot 235034601 is a gummy certificate from 2023, not this capsule. A third certificate for lot 240539 is explicitly for Biogénique Hawthorn. Neither is evidence for the saleable Vitamin D3 capsule batch. Before publication, the quality-control system should surface one in-date certificate that matches the bottle's product name, dosage form, lot, expiry and formulation.

How to use Vitamin D3 1,000 IU responsibly

1. Confirm the current bottle. Check NPN 80086934, 25 mcg/1,000 IU, one-capsule adult direction, ingredients, lot and expiry.

2. Count every source. Include multivitamins, calcium-plus-D, D3+K2, cod liver oil and fortified products before judging the total.

3. Take it consistently. A meal or snack containing some fat is practical; morning versus evening is mainly a routine choice.

4. Use testing selectively. Ask whether a 25(OH)D result would change care when risk factors, symptoms or treatment make deficiency more likely.

5. Ask for individualized advice with medicines, kidney or parathyroid disease, high calcium, malabsorption, pregnancy, breastfeeding or a prescribed deficiency-treatment plan.

Frequently asked questions

Is 1,000 IU of vitamin D3 safe every day?

For most healthy adults, 1,000 IU/day is below the 4,000 IU adult UL. It is not automatically appropriate for every person, and total intake from all supplements matters. Follow the current bottle and obtain individualized advice when medicines or medical conditions affect calcium or vitamin D metabolism.

Is 25 mcg the same as 1,000 IU?

Yes. One microgram of vitamin D equals 40 IU, so 25 micrograms equals 1,000 IU. The label is expressing one amount in two units.

Should I take vitamin D3 in the morning or at night?

No strong evidence makes one time universally best. Choose a consistent time, preferably with a meal or snack containing some fat. Follow medicine-separation advice from a pharmacist if it applies to you.

Should vitamin D3 be taken with food?

Vitamin D is fat-soluble, and dietary fat can enhance absorption. Some vitamin D is absorbed without fat, so the practical goal is consistency rather than a rigid meal rule.

Does vitamin D3 prevent colds or flu?

Vitamin D supports normal immune function, but this product is not licensed to prevent or treat colds or influenza. Evidence varies, and supplementation should not replace vaccination, testing or indicated treatment.

Do I need vitamin K2 with vitamin D3?

Vitamin D3 can be used as a licensed single ingredient and does not universally require K2. People taking warfarin or another vitamin-K-sensitive anticoagulant should not add K2 without professional advice. Keep the single-ingredient D3 decision separate from marketing claims about combination products.

How do I know if I am deficient?

Serum 25-hydroxyvitamin D is the main status marker, but routine testing is not needed for every healthy person. A clinician can decide whether risk factors, symptoms, osteoporosis, malabsorption, kidney or liver disease, medicines or treatment make testing useful.

Does the COA prove 1,000 IU potency?

No. The reviewed capsule certificate lists 1,000 IU as the formula but does not include a finished-product vitamin D3 assay result. It is also expired. A current, lot-matched potency result is needed before making that claim for saleable inventory.

Bottom line

Vitamin D3 supports calcium and phosphorus absorption, bones and teeth, and normal immune function. Biogénique Vitamin D3 supplies 25 mcg/1,000 IU of cholecalciferol per capsule, with a licensed adult direction of one capsule daily. The dose is below the adult UL, but it should be interpreted alongside Canadian food and supplement guidance, every other vitamin D source, individual risk factors and—when clinically useful—a 25(OH)D test.

Take it consistently, preferably with some dietary fat, and do not turn nutrient biology into disease-prevention promises. Before this article is published, Biogénique should remove the wrong-NPN label file, confirm the saleable lot, supply an in-date lot-matched capsule COA, reconcile non-medicinal ingredients and keep single-ingredient D3 content distinct from the K2 combination page.

Related resources

• Biogénique Vitamin D3 product page

• Biogénique Quality Control / COA

• Health Canada licensed-product record - NPN 80086934

• Health Canada vitamin D guidance

Evidence & compliance note

Licensed nutrient-function claims are separated from disease-treatment promises. The 1,000 IU amount is compared with Canadian public-health guidance, DRIs and the adult UL for scale—not individualized prescribing. Fracture, infection, mood, cardiovascular and cancer evidence is described with its limits. Product facts come from the licence, issuance letter, approved image, artwork, live page and lot-specific reports. Wrong-NPN artwork, an expired capsule COA, a gummy report and the Hawthorn lot mismatch remain explicit publication holds.

References

1.  Health Canada - Biogénique Vitamin D3, NPN 80086934 — licensed product identity and conditions of use

2.  Health Canada - Product Licence and Issuance Letter, file 588533 — NPN, ingredient, 25 mcg dose, adult direction, authorized purposes and blood-thinner warning

3.  Health Canada - Vitamin D — food and supplement guidance, sunlight factors and Canadian food sources

4.  Health Canada - Dietary reference intakes: vitamins — age-specific vitamin D RDAs and ULs

5.  Health Canada - Notice of Amendment: Vitamin D, 22 February 2021 — 2,500 IU non-prescription maximum and RDA-versus-UL context

6.  NIH Office of Dietary Supplements - Vitamin D: Fact Sheet for Health Professionals — physiology, absorption, 25(OH)D testing, risk groups, evidence limits, toxicity and interactions

7.  LeBoff et al. - Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults — VITAL ancillary fracture trial in generally healthy adults

8.  Biogénique - Vitamin D3 product page — 1,000 IU formula, 60-count SKU, direction and current consumer positioning

9.  Biogénique - Quality Control / COA search — public lot-search context and required batch traceability

Disclaimer

This article is for educational purposes only and is not medical advice. Follow the current product label. Consult a qualified health professional before use if you take blood thinners or other medication, are pregnant or breastfeeding, have kidney disease, kidney stones, high blood calcium, hyperparathyroidism, sarcoidosis, malabsorption, or are being treated for vitamin D deficiency. Seek medical care for severe weakness, confusion, persistent vomiting, dehydration, abnormal heart rhythm symptoms or other concerning symptoms. Keep out of reach of children.